This study addresses three important questions concerning personalized health care: (1) Are outcome differences between hospitals heterogeneous across patients? (2) If they are, how valuable is patient-centric information (that accounts for heterogeneity) to patients in selecting a hospital? and...

Close to 90% of drugs consumed in the US are generics, representing around 30% of the overall drug expenditure. Generic drugs have saved the healthcare system over 2.4 trillion dollars over the past decade. Such cost-saving benefit, however, can only be realized when the drug's effectiveness is...

US policymakers place a high priority on tying Medicare payments to the value of care delivered. A critical part of this effort is the Hospital Value-based Purchasing Program (HVBP), which rewards or penalizes hospitals based on their quality and episode-based costs of care. Within HVBP, each...

US policymakers place a high priority on tying Medicare payments to the value of care delivered. A critical part of this effort is the Hospital Value-based Purchasing Program (HVBP), which rewards or penalizes hospitals based on their quality and episode-based costs of care. Within HVBP, each...